Leading Minds by Life Sciences Voice

By: Life Sciences Voice
Listen for free

  • Summary

  • Leading Minds podcast by Life Sciences Voice delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive the industry forward. We go beyond the name and the title to unravel their personality, their beliefs, their mission, and most importantly, to understand how their brilliant minds are changing the world for the better while fueling growth for their companies and their teams. Whether you are on a leadership path of your own, or just here to learn from the experiences of these great leaders, this is the podcast for you! Lifescivoice.com Linkedin Facebook Twitter
    2022
    Show More Show Less
Economics
Show More Show Less
Episodes
  • Paul Bedard & Jassi Chadha: Reimagining The Future of Pharma Customer Engagement

    Paul Bedard & Jassi Chadha: Reimagining The Future of Pharma Customer Engagement
    Nov 12 2024
    On this episode of the Leading Minds, hosted by Jasmeet Sawhney, Jassi Chadha, President and CEO of Axtria, and Paul Bedard, Senior Vice President of Customer Engagement at Bayer US, dive into how customer-centric models are reshaping healthcare. Paul discusses Bayer’s implementation of Dynamic Shared Ownership (DSO), a transformative approach where teams work in 90-day cycles, focusing on outcomes and giving individuals autonomy to drive results. Jassi expands on how digital technology and data analytics are critical in refining customer engagement and utilizing AI to provide physicians with valuable insights from data they wouldn’t otherwise have access to. Together, they explore how innovations in AI, machine learning, and personalized customer engagement are shaping the future of healthcare and address the evolving challenges in pricing and accessibility. Their conversation culminates in advice for up-and-coming leaders in customer engagement, particularly in the life sciences industry. IN THIS EPISODE: [3:37] Paul discusses Bayer’s reinvention of its organization to make it customer-centric by implementing Dynamic Shared Ownership (DSO) [6:14] Jassi speaks to the implementation of DSO [7:49] Paul dives deeper into outcomes measured every 90 days [9:40] Jassi explains how digital technology and data analytics play a role in customer engagement and defines how pharma customers are unique [14:39] Paul shares how machine learning has been utilized in the past and what he anticipates going forward [17:52] Jassi shares how customers are leveraging AI and how to show doctors multiple patient case studies they have no access to [23:39] Paul and Jassi discuss trends shaping customer engagement and solving more complex genetic diseases [27:54] The guests advise up-and-coming leaders in the customer engagement space in the life sciences industry [31:47] Jasmeet asks Jassi and Paul rapid-fire questions KEY TAKEAWAYS: The future of customer engagement in healthcare is shifting as health systems standardize and access to new products becomes more challenging. Organizations must adapt by demonstrating early value and offering support services, such as helping patients navigate Medicare changes. As treatments become more complex and innovative, engaging customers with thoughtful, targeted solutions will be key to staying relevant. Balancing innovation with accessibility and affordability will ensure continued success in this evolving landscape. Customer engagement in healthcare will be shaped by the increasing complexity and innovation in treatments, particularly in areas like gene therapy, rare diseases, and oncology. As scientific advancements lead to more nuanced and targeted therapies, patients and payers are demanding clearly defined outcomes. This trend will intensify as healthcare systems grapple with pricing models and ensure access to these cutting-edge treatments. The key to successful customer engagement will be balancing innovation with practical solutions for affordability and accessibility, ensuring that transformative treatments reach the patients who need them. A big part of the future of pharma customer engagement is how we serve patients better and make therapies affordable and accessible to people worldwide. AI and machine learning are transforming how pharma companies engage with customers by enabling more personalized, data-driven interactions. Predictive analytics, like "next best action," help target the right customers at the right time, improving outcomes for both patients and providers. As AI continues to evolve, it will enhance decision-making, streamline processes, and ensure meaningful engagement, even in virtual settings. Embracing these technologies will be key to staying competitive and delivering value in the future. RESOURCE LINKS: Podcast - Leading Minds Jasmeet Sawhney - LinkedIn Jaswinder Chadha - LinkedIn Paul Bedard - LinkedIn BIOGRAPHIES: YOUR HOST: Jasmeet Sawhney is a life sciences industry executive, marketing leader, and serial entrepreneur with deep roots in technology and data analytics. He is currently the global head of marketing at Axtria. Jasmeet has over 20 years of experience in life sciences and has helped build and scale three successful companies. He has received several company and individual awards, including Inc 500, Deloitte Fast 500, Crain’s NY Fast 50, NJBiz Fast 50, Business of the Year, SmartCEO Future 50, Top CMO, Forty Under 40, and many more. GUESTS: Jassi Chadha currently serves as President & CEO of Axtria. Since its founding in 2010, Axtria has become one of the biggest global leaders in the industry, with customers in over 135 countries. Previously, Jassi was co-founder and CEO of marketRx, acquired by Cognizant Technology Solutions. Jassi and his companies have been featured in some of the most aspirational lists - INC 500, Deloitte FAST 50, NJBiz FAST 50, SmartCEO Future 50, Red Herring, and...
    Show More Show Less
    35 mins
  • Michael Bailey: Winning for Cancer Patients with Purpose and Perseverance

    Michael Bailey: Winning for Cancer Patients with Purpose and Perseverance
    Apr 30 2024

    Join us for an insightful discussion with Michael Bailey, CEO of AVEO Oncology. Michael and Jasmeet delve into the realities of career growth, exploring both the triumphs and setbacks. Michael, a strong advocate for active listening, shares how this skill empowers leaders. He'll discuss the common pitfalls of aspiring leaders feeling pressure to climb the ladder quickly, which leads to taking shortcuts or neglecting a solid foundation, ultimately hindering long-term success. Michael also introduces his concept of the five E's of life and career. Don't miss this valuable episode packed with leadership insights!

    IN THIS EPISODE:

    • [3:02] Michael provides an overview of his professional journey

    • [6:30] Michael outlines some setbacks and failures he has experienced

    • [11:29] Discussion on mergers and acquisitions

    • [15:21] Michael describes the goals he has for the company and the importance of being reputable

    • [19:35] Michael discusses the future he sees in biotech and the value of mentors

    • [26:10] Michael gives advice to up-and-coming leaders and describes how he continues to learn

    • [29:50] Michael shares how he balances his personal and professional lives

    • [33:11] Jasmeet asks Michael rapid-fire questions

    KEY TAKEAWAYS:

    • [7:53] The FDA is in place to bring patients the best and safest therapies. It’s essential to listen to them when conducting and designing studies.

    • [11:14] During an acquisition, it must be a strategic fit. There should be a common goal and mission.

    • [16:45] Your company's reputation is essential to establish it in the marketplace for long-term success.

    RESOURCE LINKS:

    Podcast - Leading Minds

    Jasmeet Sawhney - LinkedIn

    Michael Bailey - LinkedIn

    BIOGRAPHIES:

    YOUR HOST: JASMEET SAWHNEY

    Jasmeet Sawhney is a life sciences industry executive, marketing leader, and serial entrepreneur with deep roots in technology and data analytics. He is currently the global head of marketing at Axtria. Jasmeet has over 20 years of experience in life sciences and has helped build and scale three successful companies. He has received several company and individual awards, including Inc 500, Deloitte Fast 500, Crain’s NY Fast 50, NJBiz Fast 50, Business of the Year, SmartCEO Future 50, Top CMO, Forty Under 40, and many more.

    Michael P. Bailey serves as president and chief executive officer for AVEO Oncology (an LG Chem company) and is a member of AVEO’s board of directors. Michael brings more than 30 years of experience in the pharmaceutical industry to the company. Before LG Chem acquired AVEO in January of 2023, Mr. Bailey was named president and chief executive officer of AVEO Oncology in January 2015. Before that appointment, Mr. Bailey served as AVEO’s chief business officer from 2013 to 2015 and its chief commercial officer from 2010 to 2013. Mr. Bailey joined AVEO from Synta (now Madrigal Pharmaceuticals), serving as senior vice president, business development, and chief commercial officer since 2008. Before joining Synta, Mr. Bailey led ImClone Systems’ (now Eli Lilly) Worldwide Commercial Organization. During his nine-year tenure at ImClone Systems, he was responsible for commercial aspects of the planning and launch of ERBITUX® (cetuximab) across multiple oncology indications, as well as new product planning for the ImClone Systems development portfolio, which included CYRAMZA® (ramucirumab) and necitumumab. In addition, Mr. Bailey was a key member of the strategic leadership committees for ImClone and its North American and worldwide partnerships. Before joining ImClone Systems, Mr. Bailey managed the cardiovascular development portfolio at Genentech, Inc., and was a key member of their global commercial partnership teams. Mr. Bailey started his career in the pharmaceutical industry as part of SmithKline Beecham’s Executive MBA Marketing Development Program, where he held various commercial roles, including sales, strategic planning, and product management. Mr. Bailey received a B.S. in psychology from St. Lawrence University and an M.B.A. in international marketing from the Mendoza College of Business at the University of Notre Dame.
    Show More Show Less
    37 mins
  • Ramona Sequeira: Building a Global Organization with Local Understanding of Patient Needs at Heart

    Ramona Sequeira: Building a Global Organization with Local Understanding of Patient Needs at Heart
    Sep 27 2023

    Today, we have the privilege of hosting Ramona Sequeira, the President of Takeda's Global Portfolio Division. She will delve into Takeda's involvement in the Life Science sector, shedding light on leadership, employee oversight, and recruitment. Ramona emphasizes three essential qualities for those aspiring to join her team: curiosity, humility, and courage. Additionally, she delves into the importance of making decisions as close to the patient as possible, tailoring strategies to the needs of specific healthcare systems and markets.

     

    IN THIS EPISODE:

     

    • [03:56] Ramona provides a background of her professional journey into her current position

    • [08:17] What are the major shifts in the industry

    • [10:43] Ramona discusses key decisions she has made during her career

    • [15:21] Ramona shares attributes she looks for in employees

    • [17:39] Keeping abreast of continuing education is critical for Ramona, and she discusses how she prioritizes her career and personal life

    • [23:32] Jasmeet asks Ramona a series of rapid-fire questions

     

    KEY TAKEAWAY:

     

    • Strategies must be tailored to the needs of specific healthcare systems and countries in order to best meet the needs of patients globally.

    • When stepping into a new role, it's crucial to ensure that you bring employees along with you by communicating the why and being clear on your vision.

    • Curiosity, humility and courage are essential to lead in a rapidly changing environment.

     

    RESOURCE LINKS:

     

    Podcast - Leading Minds

     

    Jasmeet Sawhney - LinkedIn

     

    Takeda - Website

     

    Ramona Sequeira - LinkedIn

     

    BIOGRAPHY:

    Ramona Sequeira is a leader in the biopharmaceutical industry, currently serving as President of Takeda's Global Portfolio Division (GPD) and as a member of Takeda's Executive Team. With a career spanning multiple markets, cultures, and healthcare systems, Ramona has launched brands and built and grown businesses for Takeda and prior to that Eli Lilly, always with an unwavering dedication to building solutions based on a deep understanding of patient needs.



    YOUR HOST: JASMEET SAWHNEY 

     

    Jasmeet Sawhney is a life sciences industry executive, marketing leader, and serial entrepreneur with deep roots in technology and data analytics. He is currently the global head of marketing at Axtria. Jasmeet has over 20 years of experience in the life sciences domain and has helped build and scale three successful companies. He has received several company and individual awards, including Inc 500, Deloitte Fast 500, Crain’s NY Fast 50, NJBiz Fast 50, Business of the Year, SmartCEO Future 50, Top CMO, Forty Under 40, and many more.

     
    Show More Show Less
    29 mins

What listeners say about Leading Minds by Life Sciences Voice

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available